BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19473055)

  • 1. Soluble form of carbonic anhydrase IX (CAIX) in transitional cell carcinoma of urinary tract.
    Hyrsl L; Zavada J; Zavadova Z; Kawaciuk I; Vesely S; Skapa P
    Neoplasma; 2009; 56(4):298-302. PubMed ID: 19473055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Kamei S; Deguchi T; Hirose Y
    Oncol Rep; 2008 Sep; 20(3):525-30. PubMed ID: 18695901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.
    Leibovich BC; Sheinin Y; Lohse CM; Thompson RH; Cheville JC; Zavada J; Kwon ED
    J Clin Oncol; 2007 Oct; 25(30):4757-64. PubMed ID: 17947723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of carbonic anhydrase IX protein in the diagnosis of malignant pleural effusion by enzyme-linked immunosorbent assay and immunocytochemistry.
    Liao ND; Lee WY
    Cancer Cytopathol; 2012 Aug; 120(4):269-75. PubMed ID: 22367930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON.
    Hoskin PJ; Sibtain A; Daley FM; Wilson GD
    Br J Cancer; 2003 Oct; 89(7):1290-7. PubMed ID: 14520462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer.
    de Martino M; Lucca I; Mbeutcha A; Wiener HG; Haitel A; Susani M; Shariat SF; Klatte T
    Eur Urol; 2015 Oct; 68(4):552-4. PubMed ID: 26138037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of carbonic anhydrase IX as a molecular marker for transitional cell carcinoma of the bladder.
    Klatte T; Belldegrun AS; Pantuck AJ
    BJU Int; 2008 Jun; 101 Suppl 4():45-8. PubMed ID: 18430124
    [No Abstract]   [Full Text] [Related]  

  • 8. Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer.
    Schütze D; Milde-Langosch K; Witzel I; Rody A; Karn T; Schmidt M; Choschzick M; Jänicke F; Müller V
    J Cancer Res Clin Oncol; 2013 May; 139(5):747-54. PubMed ID: 23358720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of carbonic anhydrase IX, PAX2 and PAX8 and their association with clinicopathologic characteristics in renal epithelial tumors].
    Zhang W; Yu WJ; Xia Y; Liu Y; Liu XL; Zhuang J; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):442-5. PubMed ID: 24246861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of carbonic anhydrase IX in oral submucous fibrosis and oral squamous cell carcinoma.
    Yang JS; Chen MK; Yang SF; Chang YC; Su SC; Chiou HL; Chien MH; Lin CW
    Clin Chem Lab Med; 2014 Sep; 52(9):1367-77. PubMed ID: 24695043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer.
    Woelber L; Kress K; Kersten JF; Choschzick M; Kilic E; Herwig U; Lindner C; Schwarz J; Jaenicke F; Mahner S; Milde-Langosch K; Mueller V; Ihnen M
    BMC Cancer; 2011 Jan; 11():12. PubMed ID: 21223596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High stromal carbonic anhydrase IX expression is associated with nodal metastasis and decreased survival in patients with surgically-treated oral cavity squamous cell carcinoma.
    Brockton NT; Klimowicz AC; Bose P; Petrillo SK; Konno M; Rudmik L; Dean M; Nakoneshny SC; Matthews TW; Chandarana S; Lau HY; Magliocco AM; Dort JC
    Oral Oncol; 2012 Jul; 48(7):615-22. PubMed ID: 22366443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials.
    Zhou GX; Ireland J; Rayman P; Finke J; Zhou M
    Urology; 2010 Feb; 75(2):257-61. PubMed ID: 19963243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker.
    Klatte T; Seligson DB; Rao JY; Yu H; de Martino M; Kawaoka K; Wong SG; Belldegrun AS; Pantuck AJ
    Cancer; 2009 Apr; 115(7):1448-58. PubMed ID: 19195047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up.
    Zhang BY; Thompson RH; Lohse CM; Dronca RS; Cheville JC; Kwon ED; Leibovich BC
    BJU Int; 2013 Jun; 111(7):1046-53. PubMed ID: 23551810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
    Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
    Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase IX, a marker of hypoxia: correlation with clinical outcome in transitional cell carcinoma of the bladder.
    Hussain SA; Palmer DH; Ganesan R; Hiller L; Gregory J; Murray PG; Pastorek J; Young L; James ND
    Oncol Rep; 2004 May; 11(5):1005-10. PubMed ID: 15069539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
    Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
    Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase IX is expressed in mesothelioma and metastatic clear cell renal cell carcinoma of the lung.
    Ramsey ML; Yuh BJ; Johnson MT; Yeldandi AV; Zynger DL
    Virchows Arch; 2012 Jan; 460(1):89-93. PubMed ID: 22143934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients' prognosis.
    Chen Y; Li X; Wu S; Xu G; Zhou Y; Gong L; Li Z; Yang D
    Med Oncol; 2014 Dec; 31(12):304. PubMed ID: 25377659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.